Literature DB >> 20712482

Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions, but elicit poor LCMV-specific IgA.

Bheemreddy Rajini1, Junwei Zeng, Pratima Krishna Suvas, Heather M Dech, Thandi M Onami.   

Abstract

Immunoglobulins in secretions play a critical role in protection at mucosal surfaces. We examined the generation of viral-specific IgG and IgA in plasma and mucosal secretions of mice following systemic or mucosal immunization with lymphocytic choriomeningitis virus (LCMV), a widely used experimental model of viral infection. While there are early differences in humoral responses depending on the route of viral entry, we show that both routes generate comparably robust viral-specific IgG in plasma, vaginal, lung, and nasal secretions of immune mice. In contrast, LCMV elicited poor viral-specific IgA responses. Mice that were infected IN showed elevated viral-specific IgA in nasal and lung washes compared to IP-infected mice; however, LCMV-specific IgG overwhelmingly contributed to the humoral response in all mucosal secretions examined. Thus similarly to HIV-1, and several other mucosally-encountered microbial infections, these data suggest that LCMV infection fails to induce vigorous viral-specific IgA responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712482      PMCID: PMC2978048          DOI: 10.1089/vim.2010.0012

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  42 in total

1.  CD4 T cell-dependent CD8 T cell maturation.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

2.  Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of mice.

Authors:  S K Rai; B K Micales; M S Wu; D S Cheung; T D Pugh; G E Lyons; M S Salvato
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Humoral immunity due to long-lived plasma cells.

Authors:  M K Slifka; R Antia; J K Whitmire; R Ahmed
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

Review 4.  Sexual transmission of HIV.

Authors:  R A Royce; A Seña; W Cates; M S Cohen
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

5.  Virus-specific IgD in acute viral infection of mice.

Authors:  D Moskophidis; M Moskophidis; J Löhler
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

6.  Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein.

Authors:  M Djavani; C Yin; L Xia; I S Lukashevich; C D Pauza; M S Salvato
Journal:  Vaccine       Date:  2000-02-14       Impact factor: 3.641

7.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

8.  Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Authors:  J A Suzich; S J Ghim; F J Palmer-Hill; W I White; J K Tamura; J A Bell; J A Newsome; A B Jenson; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.

Authors:  Juan D Rodas; Igor S Lukashevich; Juan C Zapata; Cristiana Cairo; Ilia Tikhonov; Mahmoud Djavani; C David Pauza; Maria S Salvato
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

10.  SAP is required for generating long-term humoral immunity.

Authors:  Shane Crotty; Ellen N Kersh; Jennifer Cannons; Pamela L Schwartzberg; Rafi Ahmed
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

View more
  1 in total

1.  Cutting edge: Expression of FcγRIIB tempers memory CD8 T cell function in vivo.

Authors:  Gabriel R Starbeck-Miller; Vladimir P Badovinac; Daniel L Barber; John T Harty
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.